Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hazard Rate01:11

Hazard Rate

525
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
525
Hazard Ratio01:12

Hazard Ratio

756
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
756
Censoring Survival Data01:09

Censoring Survival Data

689
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
689
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

712
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

492
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
492
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

955
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
955

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continuous electricity from charged total dissolved solids in wastewater using a wood-based ion-selective power generator.

Nature communications·2026
Same author

Reprogramming Acetaminophen Metabolism via Amide-to-Thioamide Modification to Prevent Drug-Induced Liver Injury.

Journal of medicinal chemistry·2026
Same author

The effectiveness of a plant-based milk with fermented brown rice on constipation symptoms via gut microbiota modulation: a double-blind randomized controlled trial.

European journal of nutrition·2026
Same author

Covalent Interaction Between High-Amylose Corn Starch and Ferulic Acid: Reshaping of the Structure.

Foods (Basel, Switzerland)·2026
Same author

Subgroup Analysis of Interval-censored Failure Time Data With Application to Alzheimer's Disease.

Statistics in medicine·2026
Same author

Clitocine suppresses TNBC progression by boosting CCRL2 to block survival signals and neutrophil-driven inflammation.

Journal of biological engineering·2026

Related Experiment Video

Updated: May 1, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K

Hazard ratio estimation for two-sample case under interval-censored failure time data.

Yanqin Feng, Jianguo Sun

    Biometrical Journal. Biometrische Zeitschrift
    |April 9, 2014
    PubMed
    Summary

    This study introduces two new nonparametric methods for estimating hazard ratios with interval-censored failure time data. These methods provide quantitative survival differences, unlike traditional p-value based approaches.

    More Related Videos

    An R-Based Landscape Validation of a Competing Risk Model
    05:37

    An R-Based Landscape Validation of a Competing Risk Model

    Published on: September 16, 2022

    2.3K
    Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
    05:16

    Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

    Published on: June 10, 2025

    803

    Related Experiment Videos

    Last Updated: May 1, 2026

    Establishing a Competing Risk Regression Nomogram Model for Survival Data
    04:57

    Establishing a Competing Risk Regression Nomogram Model for Survival Data

    Published on: October 23, 2020

    9.9K
    An R-Based Landscape Validation of a Competing Risk Model
    05:37

    An R-Based Landscape Validation of a Competing Risk Model

    Published on: September 16, 2022

    2.3K
    Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
    05:16

    Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

    Published on: June 10, 2025

    803

    Area of Science:

    • Biostatistics
    • Survival Analysis
    • Medical Statistics

    Background:

    • Interval-censored failure time data presents unique challenges in statistical analysis.
    • Existing nonparametric methods often lack quantitative measures like hazard ratios for comparing samples or treatments.

    Purpose of the Study:

    • To develop and evaluate nonparametric procedures for estimating the hazard ratio in two-sample comparisons with interval-censored data.
    • To address the limitation of existing methods that do not provide direct quantitative measures of treatment effects.

    Main Methods:

    • Generalizing existing nonparametric procedures for right-censored data to accommodate interval-censored failure time data.
    • Developing two distinct nonparametric estimation procedures for the hazard ratio.

    Main Results:

    • An extensive simulation study demonstrated the reasonable performance of the proposed procedures.
    • The methods were successfully applied to real-world interval-censored data from a breast cancer study.

    Conclusions:

    • The developed nonparametric procedures effectively estimate hazard ratios for interval-censored data.
    • These methods offer a valuable quantitative tool for survival analysis and treatment comparison in clinical research.